BG62328B1 - Метод за синтезиране на междинни съединения на заместениимидазолови съединения - Google Patents

Метод за синтезиране на междинни съединения на заместениимидазолови съединения Download PDF

Info

Publication number: BG62328B1
Authority: BG; Bulgaria
Prior art keywords: alkyl; phenyl; substituted; unsubstituted; naphthyl
Prior art date: 1992-09-23

Application number

BG99520A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG99520A (bg

Inventor

Mohamed K. Mokhallalati

Lendon N. Pridgen

Susan Shilcrat

Joseph Weinstock

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-23

Filing date

1995-03-23

Publication date

1999-08-31

1995-03-23 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

1996-01-31 Publication of BG99520A publication Critical patent/BG99520A/bg

1999-08-31 Publication of BG62328B1 publication Critical patent/BG62328B1/bg

Links

238000000034 method Methods 0.000 title claims abstract description 25
150000001875 compounds Chemical class 0.000 title claims abstract description 24
150000002460 imidazoles Chemical class 0.000 title description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 19
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 16
125000000217 alkyl group Chemical group 0.000 claims description 13
229910052794 bromium Inorganic materials 0.000 claims description 13
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
238000002360 preparation method Methods 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
229910052801 chlorine Inorganic materials 0.000 claims description 11
125000001624 naphthyl group Chemical group 0.000 claims description 11
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
229910052731 fluorine Inorganic materials 0.000 claims description 10
-1 tetrazole-5- yl Chemical group 0.000 claims description 10
229910052740 iodine Inorganic materials 0.000 claims description 9
239000004305 biphenyl Substances 0.000 claims description 8
235000010290 biphenyl Nutrition 0.000 claims description 8
239000001257 hydrogen Substances 0.000 claims description 8
229910052739 hydrogen Inorganic materials 0.000 claims description 8
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 8
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
125000001424 substituent group Chemical group 0.000 claims description 8
229910052799 carbon Inorganic materials 0.000 claims description 7
239000002904 solvent Substances 0.000 claims description 7
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 5
125000000304 alkynyl group Chemical group 0.000 claims description 4
229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
150000003839 salts Chemical class 0.000 claims description 4
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
QLMGJDCOKQGJKF-UHFFFAOYSA-N 4-[(2-butyl-5-formylimidazol-1-yl)methyl]benzoic acid Chemical compound CCCCC1=NC=C(C=O)N1CC1=CC=C(C(O)=O)C=C1 QLMGJDCOKQGJKF-UHFFFAOYSA-N 0.000 claims description 3
125000003342 alkenyl group Chemical group 0.000 claims description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
125000003545 alkoxy group Chemical group 0.000 claims description 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
QWVFYZAYKGIEFP-UHFFFAOYSA-N 4-[(2-butyl-5-formylimidazol-1-yl)methyl]naphthalene-1-carboxylic acid Chemical compound CCCCC1=NC=C(C=O)N1CC1=CC=C(C(O)=O)C2=CC=CC=C12 QWVFYZAYKGIEFP-UHFFFAOYSA-N 0.000 claims 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
125000004414 alkyl thio group Chemical group 0.000 claims 1
102000008873 Angiotensin II receptor Human genes 0.000 abstract description 2
108050000824 Angiotensin II receptor Proteins 0.000 abstract description 2
208000010412 Glaucoma Diseases 0.000 abstract description 2
206010019280 Heart failures Diseases 0.000 abstract description 2
206010020772 Hypertension Diseases 0.000 abstract description 2
208000001647 Renal Insufficiency Diseases 0.000 abstract description 2
201000006370 kidney failure Diseases 0.000 abstract description 2
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 14
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
239000011541 reaction mixture Substances 0.000 description 10
239000000243 solution Substances 0.000 description 9
239000000725 suspension Substances 0.000 description 9
239000000543 intermediate Substances 0.000 description 8
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
239000012299 nitrogen atmosphere Substances 0.000 description 6
UCDIXJKWUCLMJK-UHFFFAOYSA-N 2-bromo-3-propan-2-yloxyprop-2-enal Chemical compound CC(C)OC=C(Br)C=O UCDIXJKWUCLMJK-UHFFFAOYSA-N 0.000 description 5
239000011521 glass Substances 0.000 description 5
239000007787 solid Substances 0.000 description 5
238000003756 stirring Methods 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
239000000203 mixture Substances 0.000 description 4
239000000047 product Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
238000001816 cooling Methods 0.000 description 3
239000007789 gas Substances 0.000 description 3
239000010410 layer Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000003960 organic solvent Substances 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
UAIVSGKSLHIONB-UHFFFAOYSA-N 1-methoxypentylideneazanium;chloride Chemical compound Cl.CCCCC(=N)OC UAIVSGKSLHIONB-UHFFFAOYSA-N 0.000 description 2
XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 2
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
SURMYNZXHKLDFO-UHFFFAOYSA-N 2-bromopropanedial Chemical compound O=CC(Br)C=O SURMYNZXHKLDFO-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
239000002585 base Substances 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
125000001309 chloro group Chemical group Cl* 0.000 description 2
RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
229910000041 hydrogen chloride Inorganic materials 0.000 description 2
239000000463 material Substances 0.000 description 2
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
150000007530 organic bases Chemical class 0.000 description 2
239000012044 organic layer Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical class ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
OCSMLBNTYKPTHZ-UHFFFAOYSA-N 2-methylpropanoic acid;propanedial Chemical compound O=CCC=O.CC(C)C(O)=O.CC(C)C(O)=O OCSMLBNTYKPTHZ-UHFFFAOYSA-N 0.000 description 1
CLYAQFSQLQTVNO-UHFFFAOYSA-N 3-cyclohexylpropan-1-ol Chemical compound OCCCC1CCCCC1 CLYAQFSQLQTVNO-UHFFFAOYSA-N 0.000 description 1
WJNGLLIRHNQREX-UHFFFAOYSA-N 4,5-dihydro-1h-imidazole-5-carbaldehyde Chemical class O=CC1CN=CN1 WJNGLLIRHNQREX-UHFFFAOYSA-N 0.000 description 1
RZUOYFGIQVKGKC-UHFFFAOYSA-N 4-[(1-aminopentylideneamino)methyl]benzoic acid Chemical compound CCCCC(=N)NCC1=CC=C(C(O)=O)C=C1 RZUOYFGIQVKGKC-UHFFFAOYSA-N 0.000 description 1
RDUCEKLOHBLLEV-UHFFFAOYSA-N 4-[(1-aminopentylideneamino)methyl]naphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(CNC(=N)CCCC)=CC=C(C(O)=O)C2=C1 RDUCEKLOHBLLEV-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
206010007559 Cardiac failure congestive Diseases 0.000 description 1
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
RFFFKMOABOFIDF-UHFFFAOYSA-N Pentanenitrile Chemical compound CCCCC#N RFFFKMOABOFIDF-UHFFFAOYSA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
125000002877 alkyl aryl group Chemical group 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
RCTFHBWTYQOVGJ-UHFFFAOYSA-N chloroform;dichloromethane Chemical class ClCCl.ClC(Cl)Cl RCTFHBWTYQOVGJ-UHFFFAOYSA-N 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
239000012043 crude product Substances 0.000 description 1
229940120503 dihydroxyacetone Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000004821 distillation Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
229960003750 ethyl chloride Drugs 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
230000026030 halogenation Effects 0.000 description 1
238000005658 halogenation reaction Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
DIFSGQKADHEBAI-UHFFFAOYSA-N methyl pentanimidate Chemical compound CCCCC(=N)OC DIFSGQKADHEBAI-UHFFFAOYSA-N 0.000 description 1
150000004682 monohydrates Chemical class 0.000 description 1
PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000002390 rotary evaporation Methods 0.000 description 1
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000012258 stirred mixture Substances 0.000 description 1
125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)

BG99520A 1992-09-23 1995-03-23 Метод за синтезиране на междинни съединения на заместениимидазолови съединения BG62328B1 (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929220068A GB9220068D0 (en)	1992-09-23	1992-09-23	Process
PCT/US1993/008390 WO1994006776A1 (fr)	1992-09-23	1993-09-07	Procede destine a synthetiser des intermediaires utiles de composes d'imidazole substitues

Publications (2)

Publication Number	Publication Date
BG99520A BG99520A (bg)	1996-01-31
BG62328B1 true BG62328B1 (bg)	1999-08-31

Family

ID=10722348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG99520A BG62328B1 (bg)	1992-09-23	1995-03-23	Метод за синтезиране на междинни съединения на заместениимидазолови съединения

Country Status (36)

Country	Link
EP (1)	EP0662961B1 (fr)
JP (1)	JPH08501307A (fr)
KR (1)	KR100297505B1 (fr)
CN (1)	CN1035613C (fr)
AP (1)	AP418A (fr)
AT (1)	ATE186531T1 (fr)
AU (1)	AU676848B2 (fr)
BG (1)	BG62328B1 (fr)
BR (1)	BR9307201A (fr)
CA (1)	CA2145181C (fr)
CZ (1)	CZ282281B6 (fr)
DE (1)	DE69327007T2 (fr)
DK (1)	DK0662961T3 (fr)
ES (1)	ES2137999T3 (fr)
FI (1)	FI113170B (fr)
GB (1)	GB9220068D0 (fr)
GR (1)	GR3032015T3 (fr)
HU (1)	HU224071B1 (fr)
IL (1)	IL107047A (fr)
MA (1)	MA22980A1 (fr)
MX (1)	MX9305844A (fr)
MY (1)	MY110202A (fr)
NO (1)	NO304688B1 (fr)
NZ (1)	NZ256223A (fr)
OA (1)	OA10138A (fr)
PH (1)	PH31154A (fr)
PL (1)	PL173450B1 (fr)
RO (1)	RO113146B1 (fr)
RU (1)	RU2128174C1 (fr)
SA (1)	SA93140423B1 (fr)
SI (1)	SI9300494A (fr)
SK (1)	SK281227B6 (fr)
TW (1)	TW409124B (fr)
UA (1)	UA41903C2 (fr)
WO (1)	WO1994006776A1 (fr)
ZA (1)	ZA936962B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9220068D0 (en) *	1992-09-23	1992-11-04	Smithkline Beecham Corp	Process
US5565577A (en) *	1992-09-23	1996-10-15	Smithkline Beecham Corporation	Process for preparing 1-alkyaryl-2-alkyl-5-formylimidazole
US7858807B2 (en)	2005-08-23	2010-12-28	Ube Industries, Ltd.	Method for producing 1-substituted-5-acylimidazole compound
KR101472686B1 (ko) *	2013-07-09	2014-12-16	씨제이헬스케어 주식회사	벤즈이미다졸 유도체의 제조방법
CN103435617B (zh) *	2013-08-22	2016-04-27	南京华安药业有限公司	一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法
CN115894192A (zh) *	2022-12-05	2023-04-04	苏州诚和医药化学有限公司	一种2-溴丙二醛的合成方法、应用及2-溴丙二醛

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU250902A1 (ru) *	1968-06-24	1989-07-30	Новокузнецкий научно-исследовательский химико-фармацевтический институт	Способ получени 4(5)-карбпропоксиимидазолил-5(4)-амида @ -бис-(2-хлорэтил)-аминофенилуксусной кислоты
JPS5671073A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	Imidazole derivative
US4482723A (en) *	1983-04-11	1984-11-13	Pfizer Inc.	Process for preparation of 4-acetyl-2-substituted-imidazoles
US4602093A (en) *	1984-02-08	1986-07-22	Merck & Co., Inc.	Novel substituted imidazoles, their preparation and use
DE3811621A1 (de) *	1988-04-07	1989-10-26	Merck Patent Gmbh	Verfahren zur herstellung von 1h-imidazol-5-carbon-saeureestern oder -nitrilen und von pyrrol-3,4-carbonsaeureestern oder -nitrilen sowie verwendung der hergestellten verbindungen zur synthese von pilocarpin
US5234917A (en) *	1989-12-29	1993-08-10	Finkelstein Joseph A	Substituted 5-(alkyl)carboxamide imidazoles
GB9220068D0 (en) *	1992-09-23	1992-11-04	Smithkline Beecham Corp	Process

1992
- 1992-09-23 GB GB929220068A patent/GB9220068D0/en active Pending
1993
- 1993-09-07 DK DK93921386T patent/DK0662961T3/da active
- 1993-09-07 CZ CZ95708A patent/CZ282281B6/cs not_active IP Right Cessation
- 1993-09-07 KR KR1019950701094A patent/KR100297505B1/ko not_active Expired - Fee Related
- 1993-09-07 AU AU48496/93A patent/AU676848B2/en not_active Ceased
- 1993-09-07 SK SK373-95A patent/SK281227B6/sk not_active IP Right Cessation
- 1993-09-07 CA CA002145181A patent/CA2145181C/fr not_active Expired - Fee Related
- 1993-09-07 AT AT93921386T patent/ATE186531T1/de active
- 1993-09-07 RU RU95108600A patent/RU2128174C1/ru not_active IP Right Cessation
- 1993-09-07 ES ES93921386T patent/ES2137999T3/es not_active Expired - Lifetime
- 1993-09-07 NZ NZ256223A patent/NZ256223A/en not_active IP Right Cessation
- 1993-09-07 BR BR9307201A patent/BR9307201A/pt active Search and Examination
- 1993-09-07 EP EP93921386A patent/EP0662961B1/fr not_active Expired - Lifetime
- 1993-09-07 UA UA95048355A patent/UA41903C2/uk unknown
- 1993-09-07 HU HU9500837A patent/HU224071B1/hu not_active IP Right Cessation
- 1993-09-07 RO RO95-00556A patent/RO113146B1/ro unknown
- 1993-09-07 WO PCT/US1993/008390 patent/WO1994006776A1/fr not_active Ceased
- 1993-09-07 JP JP6508126A patent/JPH08501307A/ja not_active Ceased
- 1993-09-07 DE DE69327007T patent/DE69327007T2/de not_active Expired - Lifetime
- 1993-09-17 AP APAP/P/1993/000565A patent/AP418A/en active
- 1993-09-17 PH PH46894A patent/PH31154A/en unknown
- 1993-09-20 MY MYPI93001904A patent/MY110202A/en unknown
- 1993-09-20 IL IL107047A patent/IL107047A/en not_active IP Right Cessation
- 1993-09-21 MA MA23293A patent/MA22980A1/fr unknown
- 1993-09-21 ZA ZA936962A patent/ZA936962B/xx unknown
- 1993-09-22 MX MX9305844A patent/MX9305844A/es unknown
- 1993-09-23 SI SI9300494A patent/SI9300494A/sl not_active IP Right Cessation
- 1993-09-23 CN CN93119602A patent/CN1035613C/zh not_active Expired - Fee Related
- 1993-10-13 TW TW082108450A patent/TW409124B/zh not_active IP Right Cessation
- 1993-12-18 SA SA93140423A patent/SA93140423B1/ar unknown
1995
- 1995-03-20 OA OA60627A patent/OA10138A/en unknown
- 1995-03-21 PL PL93308173A patent/PL173450B1/pl unknown
- 1995-03-22 FI FI951350A patent/FI113170B/fi not_active IP Right Cessation
- 1995-03-22 NO NO951082A patent/NO304688B1/no not_active IP Right Cessation
- 1995-03-23 BG BG99520A patent/BG62328B1/bg unknown
1999
- 1999-11-30 GR GR990403109T patent/GR3032015T3/el unknown

Also Published As

Publication number	Publication date
EP0662961A4 (fr)	1996-07-31
GB9220068D0 (en)	1992-11-04
BG99520A (bg)	1996-01-31
KR100297505B1 (ko)	2001-10-24
ES2137999T3 (es)	2000-01-01
CZ282281B6 (cs)	1997-06-11
RU95108600A (ru)	1997-01-10
SK37395A3 (en)	1995-08-09
KR950703536A (ko)	1995-09-20
SA93140423B1 (ar)	2005-10-01
HK1012357A1 (en)	1999-07-30
PL308173A1 (en)	1995-07-24
CN1092411A (zh)	1994-09-21
FI113170B (fi)	2004-03-15
AP9300565A0 (en)	1993-10-31
AU4849693A (en)	1994-04-12
AU676848B2 (en)	1997-03-27
NO951094D0 (no)	1995-03-22
NO304688B1 (no)	1999-02-01
SK281227B6 (sk)	2001-01-18
MX9305844A (es)	1994-03-31
NO951094L (no)	1995-03-22
IL107047A0 (en)	1993-12-28
HU9500837D0 (en)	1995-05-29
FI951350A0 (fi)	1995-03-22
TW409124B (en)	2000-10-21
BR9307201A (pt)	1999-03-30
ZA936962B (en)	1994-08-01
PH31154A (en)	1998-03-20
IL107047A (en)	1998-04-05
AP418A (en)	1995-10-24
CA2145181A1 (fr)	1994-03-31
HUT71335A (en)	1995-11-28
MY110202A (en)	1998-02-28
JPH08501307A (ja)	1996-02-13
FI951350L (fi)	1995-03-22
SI9300494A (en)	1994-03-31
NZ256223A (en)	1996-06-25
CA2145181C (fr)	2004-11-16
RO113146B1 (ro)	1998-04-30
DK0662961T3 (da)	2000-04-17
GR3032015T3 (en)	2000-03-31
MA22980A1 (fr)	1994-04-01
WO1994006776A1 (fr)	1994-03-31
OA10138A (en)	1996-12-18
DE69327007D1 (de)	1999-12-16
ATE186531T1 (de)	1999-11-15
UA41903C2 (uk)	2001-10-15
RU2128174C1 (ru)	1999-03-27
HU224071B1 (hu)	2005-05-30
EP0662961B1 (fr)	1999-11-10
DE69327007T2 (de)	2000-04-20
EP0662961A1 (fr)	1995-07-19
CN1035613C (zh)	1997-08-13
CZ70895A3 (en)	1995-11-15
PL173450B1 (pl)	1998-03-31

Publication	Publication Date	Title
JP7353296B2 (ja)	2023-09-29	スピロケタール－置換環状ケトエノール類の製造方法
KR20170029506A (ko)	2017-03-15	4-알콕시-3-히드록시피콜린산의 제조 방법
BG62328B1 (bg)	1999-08-31	Метод за синтезиране на междинни съединения на заместениимидазолови съединения
US4966967A (en)	1990-10-30	3,4,5,6-tetrahydro-2H-1,7,4-benzodioxazonines as cardiovascular agents
EP0427335A1 (fr)	1991-05-15	Procédé aqueux pour la préparation de 5-méthyl-N-(aryl)-1,2,4-triazolo(1,5-a)pyrimidine-2-sulfonamides
US5565577A (en)	1996-10-15	Process for preparing 1-alkyaryl-2-alkyl-5-formylimidazole
PL190946B1 (pl)	2006-02-28	Związki 2-tiotiazolidyn-5-onu, sposoby ich wytwarzania oraz sposoby wytwarzania związków 2-imidazolidyn-5-onu
US20090124677A1 (en)	2009-05-14	Method For Obtaining A Pharmaceutically Active Compound (Irbesartan) And Its Synthesis Intermediate
EP1211239A1 (fr)	2002-06-05	Procedes de preparation de composes 2,3-dihydroazepine
HK1012357B (en)	2000-05-05	Process of synthesizing useful intermediates of substituted imidazole compounds
RU2786670C1 (ru)	2022-12-23	Способ получения 3-азолилпропанолов
GB1596376A (en)	1981-08-26	4,5-disubstituted imidazole-2-thiones processes for their preparation and their use as intermediates
NZ264883A (en)	1995-12-21	5-phenylpyrazolyl-3-oxy derivatives and pharmaceutical compositions
JP2002155058A (ja)	2002-05-28	１位置換ヒダントイン類の製造方法
HUT71624A (en)	1996-01-29	Optically active alkylammonium(amino-3phenyl)-1ethanesulfonate derivatives, preparation and use thereof
CN1315781C (zh)	2007-05-16	制备4－氨基－1－萘酚醚类化合物的方法
EP1359149B1 (fr)	2008-12-31	Procédé de préparation de dérivés de la triazolopyrimidine
JPH1059960A (ja)	1998-03-03	５−（アルコキシメチル）−２，３−ピリジンジカルボキシミド化合物の製造方法